Meeting Banner
Abstract #3428

Assessment of the Serine Synthesis Pathway During Breast Cancer Progression Using 13C-MRS

Dania Daye1, 2, Suzanne Wehrli3, Chris Sterner, 24, Tien-Chi Pan, 24, Mitchell D. Schnall5, Lewis A. Chodosh, 24

1Department of Bioengineering, University of Pennsylvania, Philadelphia, PA , United States; 2Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, United States; 3NMR Core Facility, Children's Hospital of Philadelphia, Philadelphia, PA, United States; 4Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA, United States; 5Department of Radiology, University of Pennsylvania, Philadelphia, PA, United States

Among women with breast cancer, tumor recurrence represents the principal cause of mortality. Nevertheless, little is known about the molecular mechanisms underlying how breast cancer recurs. In particular, while dysregulated metabolism has long been recognized as a key feature of cancer development, the metabolic changes accompanying cancer recurrence are largely unexplored. Increased serine biosynthesis has been recently found to be important in tumorigenesis. Yet, no association has been established between this metabolic pathway and cancer progression. In this study, we investigate the differences in serine metabolism between primary and recurrent mammary tumors and assess their role as potential prognostic markers.

Abstract PDF Presentation Video

Keywords

accurately acid acorn activity address allow among assess assessed assessment association available bearing bioengineering biology bore breast cancer carbon cause cell cells children clinical combined commonly conditions conducted confirmed consistent contributing converted core date decreased degrees derived described development diagnosed disease dissected diversion dormancy enzymes established eventually exhibited express expression extraction facility family feature females findings free frozen gene genetics glands glucose glycine highlighting human immediately improvements indicate inducible infusion known laboratory largely lewis limiting liquid little long mammary marker mass materials mechanisms metabolic metabolism mice minimal minutes models molecular moody mortality mouse nature needed nevertheless nitrogen nuts oncogene overnight particular pathway patients period potential prediction preliminary prevention previously primary principal produced production prognostic progression radiology recapitulate recently recognized recur recurrence recurrent relapse related represents residual revealed role sample series software solution spectra spectral spectrometer spectroscopy step sterner suggest survival survive synthesis tail therapy translational treatment tumor tumors unexplored wide women